Cite
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study
MLA
Eugene Yu-hin Chan, et al. “Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.” Journal of the American Society of Nephrology : JASN, vol. 33, no. 6, Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7c8d43b04dc0f2fc3a72b3d0f484208b&authtype=sso&custid=ns315887.
APA
Eugene Yu-hin Chan, Ellen L.M. Yu, Andrea Angeletti, Zainab Arslan, Biswanath Basu, Olivia Boyer, Chang-Yien Chan, Manuela Colucci, Guillaume Dorval, Claire Dossier, Stefania Drovandi, Gian Marco Ghiggeri, Debbie S. Gipson, Riku Hamada, Julien Hogan, Kenji Ishikura, Koichi Kamei, Markus J. Kemper, Alison Lap-tak Ma, … Kjell Tullus. (2021). Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study. Journal of the American Society of Nephrology : JASN, 33(6).
Chicago
Eugene Yu-hin Chan, Ellen L.M. Yu, Andrea Angeletti, Zainab Arslan, Biswanath Basu, Olivia Boyer, Chang-Yien Chan, et al. 2021. “Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.” Journal of the American Society of Nephrology : JASN 33 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7c8d43b04dc0f2fc3a72b3d0f484208b&authtype=sso&custid=ns315887.